These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37570828)

  • 1. Investigation on Novel
    Paolino M; de Candia M; Purgatorio R; Catto M; Saletti M; Tondo AR; Nicolotti O; Cappelli A; Brizzi A; Mugnaini C; Corelli F; Altomare CD
    Molecules; 2023 Aug; 28(15):. PubMed ID: 37570828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation.
    Kumar S; Jaiswal S; Gupta SK; Ayyannan SR
    J Biomol Struct Dyn; 2024 Jun; 42(9):4710-4729. PubMed ID: 37345530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Synthesis of Racemic
    Guieu B; Lecoutey C; Legay R; Davis A; Sopkova de Oliveira Santos J; Altomare CD; Catto M; Rochais C; Dallemagne P
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.
    Zou D; Liu R; Lv Y; Guo J; Zhang C; Xie Y
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270781. PubMed ID: 37955252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanobiphenyls: Novel H
    Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
    Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
    Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
    Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study.
    Mateev E; Kondeva-Burdina M; Georgieva M; Zlatkov A
    J Mol Graph Model; 2023 Jul; 122():108471. PubMed ID: 37087882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
    Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
    CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
    Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
    Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
    He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
    Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
    Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors.
    Hu Z; Zhou S; Li J; Li X; Zhou Y; Zhu Z; Xu J; Liu J
    Future Med Chem; 2023 Oct; 15(20):1823-1841. PubMed ID: 37902028
    [No Abstract]   [Full Text] [Related]  

  • 14. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors.
    Pisani L; Iacobazzi RM; Catto M; Rullo M; Farina R; Denora N; Cellamare S; Altomare CD
    Eur J Med Chem; 2019 Jan; 161():292-309. PubMed ID: 30366255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
    Jabir NR; Rehman MT; Tabrez S; Alserihi RF; AlAjmi MF; Khan MS; Husain FM; Ahmed BA
    Curr Pharm Des; 2021; 27(20):2425-2434. PubMed ID: 33634754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease.
    Li X; Li T; Zhan F; Cheng F; Lu L; Zhang B; Li J; Hu Z; Zhou S; Jia Y; Allen S; White L; Phillips J; Zhu Z; Xu J; Yao H
    ACS Chem Neurosci; 2022 Dec; 13(23):3488-3501. PubMed ID: 36383455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.